Unprecedented progress has been made recently on Operation Warp Speed — the effort by the Defense Department, Health and Human Services, other federal agencies and private industry to develop a coronavirus vaccine, an HHS official said today.
In a telephone briefing with reporters, HHS policy deputy chief of staff Paul Mango said, “We’re very, very pleased with where we are.” He was joined on the media conference call by Dr. Janet Woodcock, M.D., the director of the centers for drug evaluation research at the Food and Drug Administration, and Dr. Jay Butler, the deputy director for infectious diseases at the Centers for Disease Control and Prevention.
Mango reminded reporters that four of the six vaccine candidates are in phase III clinical trials, and added that the Food and Drug Administration continues to review vaccine safety information on the candidates.
